

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.84885495 |
| 2 | ensheathment of neurons (GO:0007272) | 7.64828951 |
| 3 | axon ensheathment (GO:0008366) | 7.64828951 |
| 4 | myelination (GO:0042552) | 7.57526872 |
| 5 | synaptic vesicle maturation (GO:0016188) | 7.23791360 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.22586176 |
| 7 | glutamate secretion (GO:0014047) | 6.50580553 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.22361599 |
| 9 | myelin maintenance (GO:0043217) | 5.97108204 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.95776341 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 5.94677017 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.65407894 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.51189006 |
| 14 | sodium ion export (GO:0071436) | 5.35639395 |
| 15 | locomotory exploration behavior (GO:0035641) | 5.27723961 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.24996519 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.19695381 |
| 18 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.17714374 |
| 19 | creatine metabolic process (GO:0006600) | 4.91069509 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.82043734 |
| 21 | cholesterol biosynthetic process (GO:0006695) | 4.77566538 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.74121569 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.68649078 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.67420569 |
| 25 | negative regulation of neurotransmitter transport (GO:0051589) | 4.63514020 |
| 26 | postsynaptic membrane organization (GO:0001941) | 4.58735521 |
| 27 | regulation of collateral sprouting (GO:0048670) | 4.55899804 |
| 28 | potassium ion homeostasis (GO:0055075) | 4.50993243 |
| 29 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.44690453 |
| 30 | establishment of mitochondrion localization (GO:0051654) | 4.41808500 |
| 31 | astrocyte development (GO:0014002) | 4.28017446 |
| 32 | potassium ion import (GO:0010107) | 4.25920670 |
| 33 | * oligodendrocyte differentiation (GO:0048709) | 4.25656810 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24563499 |
| 35 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.24169878 |
| 36 | negative regulation of protein localization to cell surface (GO:2000009) | 4.22993741 |
| 37 | glycerophospholipid catabolic process (GO:0046475) | 4.18976375 |
| 38 | apical protein localization (GO:0045176) | 4.15646961 |
| 39 | sterol biosynthetic process (GO:0016126) | 4.15103058 |
| 40 | photoreceptor cell differentiation (GO:0046530) | 4.13720640 |
| 41 | eye photoreceptor cell differentiation (GO:0001754) | 4.13720640 |
| 42 | asymmetric protein localization (GO:0008105) | 4.12228041 |
| 43 | peripheral nervous system axon ensheathment (GO:0032292) | 4.12112749 |
| 44 | myelination in peripheral nervous system (GO:0022011) | 4.12112749 |
| 45 | L-amino acid import (GO:0043092) | 4.06968144 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.06227211 |
| 47 | vocalization behavior (GO:0071625) | 4.00468710 |
| 48 | response to redox state (GO:0051775) | 3.99101572 |
| 49 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.97680904 |
| 50 | exploration behavior (GO:0035640) | 3.95741606 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.94571410 |
| 52 | neurotransmitter transport (GO:0006836) | 3.92489736 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.92257418 |
| 54 | response to methylmercury (GO:0051597) | 3.91836719 |
| 55 | * substantia nigra development (GO:0021762) | 3.89196863 |
| 56 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.87819785 |
| 57 | presynaptic membrane organization (GO:0097090) | 3.86389119 |
| 58 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.84894878 |
| 59 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81963813 |
| 60 | virion attachment to host cell (GO:0019062) | 3.80477167 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 3.80477167 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 3.77389147 |
| 63 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.71769526 |
| 64 | isoprenoid biosynthetic process (GO:0008299) | 3.68837965 |
| 65 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.68412524 |
| 66 | regulation of synaptic plasticity (GO:0048167) | 3.63650324 |
| 67 | response to lipoprotein particle (GO:0055094) | 3.62593564 |
| 68 | acidic amino acid transport (GO:0015800) | 3.62076767 |
| 69 | amyloid precursor protein metabolic process (GO:0042982) | 3.58591079 |
| 70 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.57805363 |
| 71 | import into cell (GO:0098657) | 3.57591452 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.56990277 |
| 73 | positive regulation of membrane potential (GO:0045838) | 3.55238388 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.55233228 |
| 75 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.52494250 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.52344977 |
| 77 | membrane tubulation (GO:0097320) | 3.50191984 |
| 78 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.50007270 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.49543034 |
| 80 | negative regulation of axonogenesis (GO:0050771) | 3.49538108 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.47870698 |
| 82 | regulation of synapse structural plasticity (GO:0051823) | 3.47601543 |
| 83 | glutamate receptor signaling pathway (GO:0007215) | 3.44282492 |
| 84 | neuromuscular process controlling posture (GO:0050884) | 3.44091029 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.44033466 |
| 86 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.43036355 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 3.42491791 |
| 88 | neuron-neuron synaptic transmission (GO:0007270) | 3.41484869 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 3.40258704 |
| 90 | cellular sodium ion homeostasis (GO:0006883) | 3.38929637 |
| 91 | protein palmitoylation (GO:0018345) | 3.38802956 |
| 92 | adult walking behavior (GO:0007628) | 3.38702890 |
| 93 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.37113118 |
| 94 | positive regulation of neurotransmitter transport (GO:0051590) | 3.36938882 |
| 95 | astrocyte differentiation (GO:0048708) | 3.36488793 |
| 96 | gamma-aminobutyric acid transport (GO:0015812) | 3.34327770 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.33082840 |
| 98 | cellular response to epinephrine stimulus (GO:0071872) | 3.32503979 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.30989526 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 3.27511992 |
| 101 | regulation of dendritic spine development (GO:0060998) | 3.26696604 |
| 102 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.24851896 |
| 103 | transmission of nerve impulse (GO:0019226) | 3.24781581 |
| 104 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.24197124 |
| 105 | L-glutamate transport (GO:0015813) | 3.23211650 |
| 106 | synaptic vesicle endocytosis (GO:0048488) | 3.21887903 |
| 107 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.21113074 |
| 108 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.19534956 |
| 109 | protein localization to synapse (GO:0035418) | 3.15949360 |
| 110 | regulation of vesicle fusion (GO:0031338) | 3.13604038 |
| 111 | GPI anchor biosynthetic process (GO:0006506) | 3.11771369 |
| 112 | proline transport (GO:0015824) | 3.10394702 |
| 113 | cerebellar Purkinje cell layer development (GO:0021680) | 3.10058279 |
| 114 | negative regulation of JUN kinase activity (GO:0043508) | 3.05621865 |
| 115 | auditory behavior (GO:0031223) | 3.04878644 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04583329 |
| 117 | amino acid import (GO:0043090) | 3.04053610 |
| 118 | glycosylceramide metabolic process (GO:0006677) | 3.03517769 |
| 119 | regulation of ARF protein signal transduction (GO:0032012) | 3.03042608 |
| 120 | peripheral nervous system development (GO:0007422) | 3.02604547 |
| 121 | glial cell development (GO:0021782) | 3.00978141 |
| 122 | regulation of synaptic transmission (GO:0050804) | 3.00832601 |
| 123 | GPI anchor metabolic process (GO:0006505) | 3.00400376 |
| 124 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00142924 |
| 125 | very long-chain fatty acid metabolic process (GO:0000038) | 2.99330848 |
| 126 | dendritic spine organization (GO:0097061) | 2.98391520 |
| 127 | long-term memory (GO:0007616) | 2.98312364 |
| 128 | neuron remodeling (GO:0016322) | 2.97883632 |
| 129 | limb bud formation (GO:0060174) | 2.97565298 |
| 130 | regulation of synapse maturation (GO:0090128) | 2.97162592 |
| 131 | axon development (GO:0061564) | 2.96135534 |
| 132 | peptidyl-cysteine modification (GO:0018198) | 2.95497750 |
| 133 | glycosphingolipid biosynthetic process (GO:0006688) | 2.95136272 |
| 134 | negative regulation of axon extension (GO:0030517) | 2.93654464 |
| 135 | enteric nervous system development (GO:0048484) | 2.92882572 |
| 136 | neuronal ion channel clustering (GO:0045161) | 2.92398503 |
| 137 | regulation of neurotransmitter uptake (GO:0051580) | 2.91142114 |
| 138 | response to epinephrine (GO:0071871) | 2.89498156 |
| 139 | neuron cell-cell adhesion (GO:0007158) | 2.89334243 |
| 140 | positive regulation of glial cell differentiation (GO:0045687) | 2.88790882 |
| 141 | magnesium ion transport (GO:0015693) | 2.88415985 |
| 142 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88303530 |
| 143 | detection of calcium ion (GO:0005513) | 2.87428421 |
| 144 | cellular response to monoamine stimulus (GO:0071868) | 2.86954239 |
| 145 | cellular response to catecholamine stimulus (GO:0071870) | 2.86954239 |
| 146 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86153150 |
| 147 | positive regulation of gliogenesis (GO:0014015) | 2.85980042 |
| 148 | membrane depolarization (GO:0051899) | 2.84797779 |
| 149 | response to auditory stimulus (GO:0010996) | 2.84534052 |
| 150 | nucleotide transmembrane transport (GO:1901679) | 2.81144647 |
| 151 | positive regulation of action potential (GO:0045760) | 2.79312492 |
| 152 | glycine transport (GO:0015816) | 2.77905552 |
| 153 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.77552828 |
| 154 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.76519405 |
| 155 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75844115 |
| 156 | response to hepatocyte growth factor (GO:0035728) | 2.74781748 |
| 157 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.74781748 |
| 158 | thioester biosynthetic process (GO:0035384) | 2.74644898 |
| 159 | acyl-CoA biosynthetic process (GO:0071616) | 2.74644898 |
| 160 | adhesion of symbiont to host (GO:0044406) | 2.74175886 |
| 161 | neuronal action potential propagation (GO:0019227) | 2.72848894 |
| 162 | regulation of lipoprotein metabolic process (GO:0050746) | 2.71245675 |
| 163 | response to lead ion (GO:0010288) | 2.68359503 |
| 164 | amyloid precursor protein catabolic process (GO:0042987) | 2.66277144 |
| 165 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.64871169 |
| 166 | nerve growth factor signaling pathway (GO:0038180) | 2.63787181 |
| 167 | iron coordination entity transport (GO:1901678) | 2.60560025 |
| 168 | response to catecholamine (GO:0071869) | 2.60169888 |
| 169 | response to monoamine (GO:0071867) | 2.60169888 |
| 170 | * neural nucleus development (GO:0048857) | 2.56692767 |
| 171 | regulation of interleukin-13 production (GO:0032656) | 2.56169955 |
| 172 | glutathione biosynthetic process (GO:0006750) | 2.53485383 |
| 173 | cerebellar granule cell differentiation (GO:0021707) | 2.53323288 |
| 174 | neurotransmitter uptake (GO:0001504) | 2.52462270 |
| 175 | positive regulation of pseudopodium assembly (GO:0031274) | 2.51117068 |
| 176 | protein localization to endosome (GO:0036010) | 2.50993955 |
| 177 | positive regulation of actin filament depolymerization (GO:0030836) | 2.49033725 |
| 178 | central nervous system myelination (GO:0022010) | 12.0849614 |
| 179 | axon ensheathment in central nervous system (GO:0032291) | 12.0849614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.93810121 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05717162 |
| 3 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.81597509 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.66878061 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.55378101 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51023546 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.49174585 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.42959480 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38652899 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37065414 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.22567692 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20393125 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.17595708 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12175180 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07714771 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07503827 |
| 17 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.06892794 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06276005 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.04995414 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.04995414 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03529461 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00845949 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97323063 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94342347 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91198324 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91176532 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90877220 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83030908 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80329898 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80062200 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.74308250 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71968230 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.71383017 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66429760 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65494931 |
| 36 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.61331367 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59348858 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51364732 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50684416 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50675881 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48782822 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47155915 |
| 43 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46781657 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45543892 |
| 45 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40766432 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40410293 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40245453 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39896139 |
| 49 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.39539490 |
| 50 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.35708845 |
| 51 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34489154 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32936216 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32650150 |
| 54 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32527631 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29789343 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27154294 |
| 57 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26729622 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26136158 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25646418 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25629160 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25545706 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24473760 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22974953 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22733293 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22377568 |
| 66 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.21420905 |
| 67 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19797999 |
| 68 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.18675848 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17161705 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16309122 |
| 71 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15321147 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15074124 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15074124 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14440064 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13656341 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13274138 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11868978 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11582879 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.10833530 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10049404 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09097308 |
| 82 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08975987 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08612114 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08419185 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07129841 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06502287 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05911732 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05142197 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02090809 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01605162 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01545119 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01375375 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99067236 |
| 94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98894223 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97559139 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97448315 |
| 97 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.96729059 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95126733 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95085987 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94608184 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94507466 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93546200 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92789520 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92541178 |
| 105 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92260231 |
| 106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91206944 |
| 107 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90884249 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90808163 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90755257 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90026150 |
| 111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89691561 |
| 112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89295741 |
| 113 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88572378 |
| 114 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87693032 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87374533 |
| 116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.87301498 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86634588 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86631415 |
| 119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85972698 |
| 120 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85642304 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85307882 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85289842 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84797020 |
| 124 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84756252 |
| 125 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.84678935 |
| 126 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84494314 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84433033 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84094496 |
| 129 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84038437 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83587544 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83357434 |
| 132 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83054931 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82625695 |
| 134 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82469875 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82354641 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82249363 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81981310 |
| 138 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81918447 |
| 139 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80571980 |
| 140 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.80024777 |
| 141 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.79903952 |
| 142 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78705446 |
| 143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76800196 |
| 144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76692253 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75841552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 5.86496007 |
| 2 | MP0003880_abnormal_central_pattern | 4.18877445 |
| 3 | MP0003690_abnormal_glial_cell | 3.50848792 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.37635947 |
| 5 | MP0004270_analgesia | 3.30479109 |
| 6 | MP0004885_abnormal_endolymph | 3.10269665 |
| 7 | MP0005171_absent_coat_pigmentation | 3.07297780 |
| 8 | MP0001529_abnormal_vocalization | 2.88360509 |
| 9 | MP0003329_amyloid_beta_deposits | 2.86472021 |
| 10 | MP0004742_abnormal_vestibular_system | 2.68924901 |
| 11 | MP0001905_abnormal_dopamine_level | 2.60387161 |
| 12 | MP0004142_abnormal_muscle_tone | 2.56641466 |
| 13 | MP0001486_abnormal_startle_reflex | 2.56429557 |
| 14 | * MP0002272_abnormal_nervous_system | 2.55642561 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.50328464 |
| 16 | * MP0003634_abnormal_glial_cell | 2.48845893 |
| 17 | MP0003136_yellow_coat_color | 2.41352840 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.35326659 |
| 19 | * MP0002064_seizures | 2.26863972 |
| 20 | MP0001485_abnormal_pinna_reflex | 2.15768186 |
| 21 | MP0005409_darkened_coat_color | 1.94872016 |
| 22 | MP0003632_abnormal_nervous_system | 1.92931001 |
| 23 | MP0005451_abnormal_body_composition | 1.92757903 |
| 24 | MP0004381_abnormal_hair_follicle | 1.91229178 |
| 25 | MP0009745_abnormal_behavioral_response | 1.90854879 |
| 26 | * MP0000778_abnormal_nervous_system | 1.89215320 |
| 27 | * MP0002229_neurodegeneration | 1.88022857 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.87781489 |
| 29 | MP0009046_muscle_twitch | 1.84388992 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.80534896 |
| 31 | MP0005410_abnormal_fertilization | 1.80010466 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.77528448 |
| 33 | MP0003879_abnormal_hair_cell | 1.76064598 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.67522253 |
| 35 | MP0000462_abnormal_digestive_system | 1.62870148 |
| 36 | MP0001984_abnormal_olfaction | 1.61628305 |
| 37 | MP0000383_abnormal_hair_follicle | 1.61020694 |
| 38 | MP0003787_abnormal_imprinting | 1.55252653 |
| 39 | MP0008569_lethality_at_weaning | 1.53326034 |
| 40 | MP0000604_amyloidosis | 1.51022913 |
| 41 | MP0003631_nervous_system_phenotype | 1.49009404 |
| 42 | MP0004134_abnormal_chest_morphology | 1.46938342 |
| 43 | MP0002572_abnormal_emotion/affect_behav | 1.41862953 |
| 44 | * MP0002882_abnormal_neuron_morphology | 1.41602700 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.38873483 |
| 46 | * MP0000955_abnormal_spinal_cord | 1.38794995 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.36438247 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.35190546 |
| 49 | MP0004043_abnormal_pH_regulation | 1.34710366 |
| 50 | MP0008260_abnormal_autophagy | 1.33760489 |
| 51 | * MP0002066_abnormal_motor_capabilities/c | 1.32575131 |
| 52 | MP0001970_abnormal_pain_threshold | 1.30342031 |
| 53 | MP0003633_abnormal_nervous_system | 1.28829084 |
| 54 | MP0003123_paternal_imprinting | 1.27515531 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.27492036 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.26754486 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.23181850 |
| 58 | MP0004147_increased_porphyrin_level | 1.22447121 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.22200916 |
| 60 | MP0004924_abnormal_behavior | 1.22200916 |
| 61 | MP0001346_abnormal_lacrimal_gland | 1.22179954 |
| 62 | MP0001963_abnormal_hearing_physiology | 1.21676081 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.20648189 |
| 64 | MP0003075_altered_response_to | 1.20471053 |
| 65 | MP0005623_abnormal_meninges_morphology | 1.16775336 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.13221725 |
| 67 | MP0003122_maternal_imprinting | 1.12762313 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.10803557 |
| 69 | * MP0002752_abnormal_somatic_nervous | 1.08810012 |
| 70 | MP0003283_abnormal_digestive_organ | 1.04313679 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.02831571 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.00602366 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.99461389 |
| 74 | MP0005408_hypopigmentation | 0.96701203 |
| 75 | MP0001177_atelectasis | 0.95241672 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.91520799 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 0.90449027 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.88690586 |
| 79 | MP0005195_abnormal_posterior_eye | 0.88675620 |
| 80 | MP0001851_eye_inflammation | 0.87600240 |
| 81 | MP0003195_calcinosis | 0.86290967 |
| 82 | MP0000647_abnormal_sebaceous_gland | 0.85948658 |
| 83 | MP0000566_synostosis | 0.84898312 |
| 84 | MP0001661_extended_life_span | 0.82664178 |
| 85 | MP0002822_catalepsy | 0.82115747 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.82057673 |
| 87 | * MP0002152_abnormal_brain_morphology | 0.81875107 |
| 88 | MP0003938_abnormal_ear_development | 0.78696906 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.77809644 |
| 90 | MP0009840_abnormal_foam_cell | 0.77724150 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.75793060 |
| 92 | MP0008874_decreased_physiological_sensi | 0.74967186 |
| 93 | MP0000467_abnormal_esophagus_morphology | 0.74411692 |
| 94 | MP0006082_CNS_inflammation | 0.73404863 |
| 95 | MP0000026_abnormal_inner_ear | 0.72468727 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.72422178 |
| 97 | MP0002736_abnormal_nociception_after | 0.72128271 |
| 98 | MP0004811_abnormal_neuron_physiology | 0.70948745 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.70910370 |
| 100 | MP0000579_abnormal_nail_morphology | 0.70819120 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.70388755 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.70256538 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.68251081 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.66151285 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.66145106 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.66125911 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.65582893 |
| 108 | MP0002184_abnormal_innervation | 0.65301738 |
| 109 | MP0002090_abnormal_vision | 0.65165353 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.64983882 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.64483383 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.64351682 |
| 113 | MP0005253_abnormal_eye_physiology | 0.63792643 |
| 114 | MP0005535_abnormal_body_temperature | 0.63540576 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.62499724 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.61860298 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.61444332 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.60802520 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.60720512 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.58900735 |
| 121 | * MP0000747_muscle_weakness | 0.58377893 |
| 122 | MP0002133_abnormal_respiratory_system | 0.56137788 |
| 123 | MP0005388_respiratory_system_phenotype | 0.56137788 |
| 124 | MP0003045_fibrosis | 0.48080122 |
| 125 | * MP0010769_abnormal_survival | 0.47860820 |
| 126 | MP0005166_decreased_susceptibility_to | 0.47731622 |
| 127 | MP0003956_abnormal_body_size | 0.46216796 |
| 128 | * MP0002082_postnatal_lethality | 0.46088684 |
| 129 | * MP0010770_preweaning_lethality | 0.46088684 |
| 130 | MP0004510_myositis | 0.45604168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.57445467 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.57445467 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.10452061 |
| 4 | Focal motor seizures (HP:0011153) | 6.01551826 |
| 5 | Cerebral hypomyelination (HP:0006808) | 5.50776324 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 5.38126897 |
| 7 | Peripheral hypomyelination (HP:0007182) | 5.22131617 |
| 8 | Focal seizures (HP:0007359) | 5.18844030 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.90215206 |
| 10 | Parakeratosis (HP:0001036) | 4.63555443 |
| 11 | Febrile seizures (HP:0002373) | 4.32429815 |
| 12 | Onion bulb formation (HP:0003383) | 4.31659755 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 4.31640572 |
| 14 | Diplopia (HP:0000651) | 4.30765913 |
| 15 | Abnormality of binocular vision (HP:0011514) | 4.30765913 |
| 16 | Abnormal auditory evoked potentials (HP:0006958) | 4.24132303 |
| 17 | Epileptic encephalopathy (HP:0200134) | 4.17677288 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.85558901 |
| 19 | Spastic gait (HP:0002064) | 3.78665785 |
| 20 | Alacrima (HP:0000522) | 3.73706708 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.68611301 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.59552541 |
| 23 | Intention tremor (HP:0002080) | 3.57853855 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.44028002 |
| 25 | Leukodystrophy (HP:0002415) | 3.42216436 |
| 26 | Dysmetria (HP:0001310) | 3.42038948 |
| 27 | Termporal pattern (HP:0011008) | 3.38403421 |
| 28 | Insidious onset (HP:0003587) | 3.38403421 |
| 29 | Mutism (HP:0002300) | 3.33464075 |
| 30 | CNS hypomyelination (HP:0003429) | 3.27480816 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.22144405 |
| 32 | Torticollis (HP:0000473) | 3.18731450 |
| 33 | Hemiparesis (HP:0001269) | 3.14337933 |
| 34 | Slow saccadic eye movements (HP:0000514) | 3.12980029 |
| 35 | Ankle clonus (HP:0011448) | 3.12042673 |
| 36 | Spastic paraparesis (HP:0002313) | 3.10759244 |
| 37 | Visual hallucinations (HP:0002367) | 3.09494200 |
| 38 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.05208105 |
| 39 | Akinesia (HP:0002304) | 3.04678042 |
| 40 | Myokymia (HP:0002411) | 3.02957731 |
| 41 | Decreased lacrimation (HP:0000633) | 2.97313887 |
| 42 | Truncal ataxia (HP:0002078) | 2.94699426 |
| 43 | Scanning speech (HP:0002168) | 2.92466498 |
| 44 | Papilledema (HP:0001085) | 2.89003651 |
| 45 | Postural instability (HP:0002172) | 2.88385351 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.85918858 |
| 47 | Premature skin wrinkling (HP:0100678) | 2.82543857 |
| 48 | Delusions (HP:0000746) | 2.81506693 |
| 49 | Abnormality of glycolysis (HP:0004366) | 2.80395596 |
| 50 | Increased serum pyruvate (HP:0003542) | 2.80395596 |
| 51 | Morphological abnormality of the inner ear (HP:0011390) | 2.79002988 |
| 52 | Tetraplegia (HP:0002445) | 2.77909108 |
| 53 | Focal dystonia (HP:0004373) | 2.75610155 |
| 54 | Hypoplastic pelvis (HP:0008839) | 2.74507434 |
| 55 | Dialeptic seizures (HP:0011146) | 2.72561221 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71052833 |
| 57 | Progressive cerebellar ataxia (HP:0002073) | 2.69098488 |
| 58 | Retinal dysplasia (HP:0007973) | 2.68707774 |
| 59 | Absence seizures (HP:0002121) | 2.68678215 |
| 60 | Apathy (HP:0000741) | 2.66833431 |
| 61 | Neuronal loss in central nervous system (HP:0002529) | 2.66748015 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.64121953 |
| 63 | Hemiplegia (HP:0002301) | 2.62635609 |
| 64 | Annular pancreas (HP:0001734) | 2.61772252 |
| 65 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.61483014 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.60091159 |
| 67 | Rigidity (HP:0002063) | 2.57496402 |
| 68 | Depression (HP:0000716) | 2.56570117 |
| 69 | Insomnia (HP:0100785) | 2.56374489 |
| 70 | Stridor (HP:0010307) | 2.52923246 |
| 71 | Clumsiness (HP:0002312) | 2.52235297 |
| 72 | Thickened helices (HP:0000391) | 2.51600296 |
| 73 | Paraparesis (HP:0002385) | 2.50611204 |
| 74 | Anxiety (HP:0000739) | 2.50391455 |
| 75 | White forelock (HP:0002211) | 2.48185391 |
| 76 | Absent septum pellucidum (HP:0001331) | 2.45751196 |
| 77 | Pheochromocytoma (HP:0002666) | 2.45514939 |
| 78 | Heterochromia iridis (HP:0001100) | 2.43876368 |
| 79 | Dysdiadochokinesis (HP:0002075) | 2.43140045 |
| 80 | Bradykinesia (HP:0002067) | 2.43023206 |
| 81 | Anteriorly placed anus (HP:0001545) | 2.42568113 |
| 82 | Poor speech (HP:0002465) | 2.42460245 |
| 83 | Diminished motivation (HP:0000745) | 2.41532288 |
| 84 | Status epilepticus (HP:0002133) | 2.40596976 |
| 85 | Patchy hypopigmentation of hair (HP:0011365) | 2.39952789 |
| 86 | Sleep apnea (HP:0010535) | 2.39079497 |
| 87 | Increased circulating renin level (HP:0000848) | 2.34350671 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34088984 |
| 89 | Ocular albinism (HP:0001107) | 2.31984817 |
| 90 | Cerebral hemorrhage (HP:0001342) | 2.30176641 |
| 91 | Foot dorsiflexor weakness (HP:0009027) | 2.27074469 |
| 92 | Spastic tetraparesis (HP:0001285) | 2.22935379 |
| 93 | Split foot (HP:0001839) | 2.21918701 |
| 94 | Iris hypopigmentation (HP:0007730) | 2.20823963 |
| 95 | Autoamputation (HP:0001218) | 2.20738245 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.20125368 |
| 97 | Hypsarrhythmia (HP:0002521) | 2.19487235 |
| 98 | Megalencephaly (HP:0001355) | 2.19161210 |
| 99 | Axonal loss (HP:0003447) | 2.18218772 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.15079547 |
| 101 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.14292586 |
| 102 | Hypoplasia of the iris (HP:0007676) | 2.12607196 |
| 103 | Action tremor (HP:0002345) | 2.11816278 |
| 104 | Decreased motor nerve conduction velocity (HP:0003431) | 2.10897576 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.10647877 |
| 106 | Poor eye contact (HP:0000817) | 2.10496754 |
| 107 | Amblyopia (HP:0000646) | 2.09670228 |
| 108 | Bowel incontinence (HP:0002607) | 2.08504784 |
| 109 | Aplasia involving bones of the extremities (HP:0009825) | 2.08383137 |
| 110 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08383137 |
| 111 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08383137 |
| 112 | Rapidly progressive (HP:0003678) | 2.07487311 |
| 113 | Choreoathetosis (HP:0001266) | 2.05830174 |
| 114 | Abnormality of the septum pellucidum (HP:0007375) | 2.05517859 |
| 115 | Muscle fiber splitting (HP:0003555) | 2.05055885 |
| 116 | Abnormality of the foot musculature (HP:0001436) | 2.04103162 |
| 117 | Coronal craniosynostosis (HP:0004440) | 2.04026091 |
| 118 | Hypomagnesemia (HP:0002917) | 2.02897380 |
| 119 | Infantile muscular hypotonia (HP:0008947) | 2.02884399 |
| 120 | Limb dystonia (HP:0002451) | 2.01846021 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 2.01290372 |
| 122 | Esophageal atresia (HP:0002032) | 1.98894508 |
| 123 | Peripheral demyelination (HP:0011096) | 1.98270312 |
| 124 | Clonus (HP:0002169) | 1.97675462 |
| 125 | Distal sensory impairment (HP:0002936) | 1.97255722 |
| 126 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.95476763 |
| 127 | Metabolic alkalosis (HP:0200114) | 1.95259043 |
| 128 | Abnormal large intestine physiology (HP:0012700) | 1.93021107 |
| 129 | Urinary incontinence (HP:0000020) | 1.92504149 |
| 130 | Postural tremor (HP:0002174) | 1.92252399 |
| 131 | Turricephaly (HP:0000262) | 1.90606931 |
| 132 | Polyphagia (HP:0002591) | 1.90543225 |
| 133 | Impaired smooth pursuit (HP:0007772) | 1.89973936 |
| 134 | Methylmalonic acidemia (HP:0002912) | 1.89947531 |
| 135 | Memory impairment (HP:0002354) | 1.86725152 |
| 136 | Gowers sign (HP:0003391) | 1.86196480 |
| 137 | Hammertoe (HP:0001765) | 1.86140187 |
| 138 | Blue irides (HP:0000635) | 1.84330281 |
| 139 | Atonic seizures (HP:0010819) | 1.83266823 |
| 140 | Partial agenesis of the corpus callosum (HP:0001338) | 1.82423772 |
| 141 | Abnormality of the salivary glands (HP:0010286) | 1.81782931 |
| 142 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81381477 |
| 143 | Cupped ear (HP:0000378) | 1.79605467 |
| 144 | Partial duplication of thumb phalanx (HP:0009944) | 1.79189578 |
| 145 | Hypokalemic alkalosis (HP:0001949) | 1.79008812 |
| 146 | Urinary urgency (HP:0000012) | 1.78616127 |
| 147 | Synostosis involving the elbow (HP:0003938) | 1.78554292 |
| 148 | Humeroradial synostosis (HP:0003041) | 1.78554292 |
| 149 | Abnormality of the lower motor neuron (HP:0002366) | 1.78290942 |
| 150 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76429007 |
| 151 | Generalized myoclonic seizures (HP:0002123) | 1.75594453 |
| 152 | Paraplegia (HP:0010550) | 1.73390446 |
| 153 | Absent speech (HP:0001344) | 1.73165407 |
| 154 | Bundle branch block (HP:0011710) | 1.73092307 |
| 155 | Diminished movement (HP:0002374) | 1.71168298 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.70467943 |
| 157 | Erythroderma (HP:0001019) | 1.68800569 |
| 158 | Abnormality of saccadic eye movements (HP:0000570) | 1.66927948 |
| 159 | Septo-optic dysplasia (HP:0100842) | 1.64652515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.95739120 |
| 2 | OXSR1 | 4.36817176 |
| 3 | NTRK3 | 4.10974937 |
| 4 | PRPF4B | 3.84756431 |
| 5 | EPHB1 | 3.31040406 |
| 6 | DAPK2 | 3.20054025 |
| 7 | PKN1 | 3.01851111 |
| 8 | BCR | 2.91253213 |
| 9 | CDK19 | 2.62176273 |
| 10 | MINK1 | 2.29519944 |
| 11 | WNK4 | 2.26771756 |
| 12 | TNIK | 2.20963851 |
| 13 | FGFR2 | 2.16381715 |
| 14 | MET | 2.14463113 |
| 15 | LIMK1 | 2.12447138 |
| 16 | MAPKAPK5 | 2.11466153 |
| 17 | UHMK1 | 2.10746249 |
| 18 | PLK2 | 2.06919687 |
| 19 | CSNK1G3 | 2.00836734 |
| 20 | PBK | 1.95688025 |
| 21 | CSNK1A1L | 1.93076825 |
| 22 | NEK6 | 1.87253879 |
| 23 | WNK1 | 1.85566268 |
| 24 | TESK2 | 1.80047132 |
| 25 | CAMKK1 | 1.73178977 |
| 26 | RIPK1 | 1.68453957 |
| 27 | ROCK2 | 1.65080046 |
| 28 | CAMK2B | 1.60027463 |
| 29 | ICK | 1.54263416 |
| 30 | CSNK1G1 | 1.52702739 |
| 31 | CSNK1G2 | 1.51758769 |
| 32 | CLK1 | 1.47696245 |
| 33 | NTRK1 | 1.44684304 |
| 34 | GRK5 | 1.41179125 |
| 35 | SGK223 | 1.38360130 |
| 36 | SGK494 | 1.38360130 |
| 37 | TYRO3 | 1.32903414 |
| 38 | CAMK2D | 1.31386636 |
| 39 | DAPK1 | 1.29916318 |
| 40 | PAK6 | 1.29507582 |
| 41 | PNCK | 1.29420839 |
| 42 | EPHA4 | 1.26465288 |
| 43 | PRKCG | 1.23307788 |
| 44 | LATS2 | 1.22495198 |
| 45 | FGR | 1.21912829 |
| 46 | MST4 | 1.19783492 |
| 47 | CASK | 1.11544553 |
| 48 | CAMK1 | 1.10789963 |
| 49 | ALK | 1.08225648 |
| 50 | CAMK2G | 1.07262032 |
| 51 | PINK1 | 1.04702323 |
| 52 | MAP3K13 | 1.01192115 |
| 53 | DYRK2 | 0.93328124 |
| 54 | MARK1 | 0.91378919 |
| 55 | CDK14 | 0.91370279 |
| 56 | BRSK1 | 0.88616286 |
| 57 | PRKCQ | 0.85360808 |
| 58 | LMTK2 | 0.84161601 |
| 59 | CDK5 | 0.83021709 |
| 60 | MARK2 | 0.82429045 |
| 61 | SIK2 | 0.79480768 |
| 62 | ARAF | 0.79450365 |
| 63 | PRKD1 | 0.78918095 |
| 64 | CDK15 | 0.78585899 |
| 65 | DDR2 | 0.77861783 |
| 66 | CAMK2A | 0.76265539 |
| 67 | TESK1 | 0.75553769 |
| 68 | SGK2 | 0.74310489 |
| 69 | CDK18 | 0.73675958 |
| 70 | IRAK2 | 0.73369025 |
| 71 | CDK11A | 0.70728220 |
| 72 | SGK3 | 0.70664091 |
| 73 | STK38 | 0.69809824 |
| 74 | PAK3 | 0.68013081 |
| 75 | KSR2 | 0.67825010 |
| 76 | SGK1 | 0.67461667 |
| 77 | PDPK1 | 0.66824359 |
| 78 | MAPK12 | 0.65261749 |
| 79 | MAPK15 | 0.63362268 |
| 80 | PHKG1 | 0.63200030 |
| 81 | PHKG2 | 0.63200030 |
| 82 | MAPK13 | 0.61321985 |
| 83 | PRKCE | 0.60451315 |
| 84 | FYN | 0.59983158 |
| 85 | PRKCH | 0.57560345 |
| 86 | MAP3K4 | 0.56748215 |
| 87 | TNK2 | 0.56656786 |
| 88 | TRPM7 | 0.55828580 |
| 89 | FES | 0.52640858 |
| 90 | MUSK | 0.52017030 |
| 91 | PTK2 | 0.51352836 |
| 92 | CAMKK2 | 0.50826610 |
| 93 | NTRK2 | 0.49449702 |
| 94 | * RPS6KA3 | 0.47739830 |
| 95 | ERBB4 | 0.47483047 |
| 96 | FRK | 0.46935946 |
| 97 | CSNK1D | 0.45756983 |
| 98 | CSNK1A1 | 0.45303325 |
| 99 | DAPK3 | 0.43682841 |
| 100 | PRKG1 | 0.41924894 |
| 101 | PAK1 | 0.40985576 |
| 102 | ITK | 0.40214327 |
| 103 | BMPR1B | 0.39068800 |
| 104 | GSK3A | 0.38629099 |
| 105 | PRKD3 | 0.38230386 |
| 106 | BRAF | 0.38060658 |
| 107 | PDK1 | 0.36983213 |
| 108 | FER | 0.36866171 |
| 109 | STK11 | 0.35537464 |
| 110 | RIPK4 | 0.35443770 |
| 111 | IRAK1 | 0.35336287 |
| 112 | MAP3K2 | 0.34948021 |
| 113 | MAP3K11 | 0.34554506 |
| 114 | CCNB1 | 0.34465020 |
| 115 | FGFR3 | 0.34340110 |
| 116 | RPS6KA5 | 0.34299197 |
| 117 | PRKACB | 0.33977326 |
| 118 | PRKCA | 0.33500932 |
| 119 | PDK2 | 0.33068325 |
| 120 | MAP2K2 | 0.31842557 |
| 121 | CAMK4 | 0.31407651 |
| 122 | MAP3K9 | 0.31278115 |
| 123 | JAK1 | 0.30264253 |
| 124 | ROCK1 | 0.29185815 |
| 125 | PDGFRB | 0.27406102 |
| 126 | INSR | 0.27397026 |
| 127 | MAPK7 | 0.24984428 |
| 128 | PRKACA | 0.24582174 |
| 129 | MAPK10 | 0.23771084 |
| 130 | DMPK | 0.23603440 |
| 131 | BMX | 0.22906929 |
| 132 | ADRBK2 | 0.21723319 |
| 133 | ILK | 0.20785765 |
| 134 | BMPR2 | 0.20067324 |
| 135 | CSK | 0.19872198 |
| 136 | GRK7 | 0.19868156 |
| 137 | PRKCZ | 0.19342086 |
| 138 | SRC | 0.18660927 |
| 139 | DYRK1A | 0.17678482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.64203060 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.67303169 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.44860219 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.44390604 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.98641267 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.97918862 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.79959301 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.71084835 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55961453 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.50699345 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.35807902 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10390839 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01515972 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.98417827 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78607353 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74024353 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71130999 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.62417485 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60580204 |
| 20 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55028603 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.48979114 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44874221 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39824549 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.37170507 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35320802 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33766974 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.32927533 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32257025 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31509544 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28129248 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28033149 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.26717969 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24738232 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24212046 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22195601 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14514853 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12505017 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10717323 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.08923772 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.06549376 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.05010525 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02739599 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02678364 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01909182 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00318908 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.98715694 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98628340 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97598576 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97382235 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97210973 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.95436197 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.95413424 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92962426 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.91466564 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86593327 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85641377 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85078283 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81289493 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80156044 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78995663 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77958474 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77832642 |
| 63 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76392315 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75994085 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.75483194 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74714629 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73991154 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71341293 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68704079 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66959819 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66424170 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66367425 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66300177 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65784011 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65595733 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65515746 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63243309 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63215748 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.62618750 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61807440 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60901547 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59847250 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59696142 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59275170 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57542624 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57503480 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.54349276 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.53790839 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53715370 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53112201 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53024995 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.52922590 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51176533 |
| 94 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50992821 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49330173 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47202940 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46823533 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46510331 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46463254 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46361587 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46297442 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46039087 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45557335 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44996169 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.44992519 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44977217 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44419892 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43183537 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41759918 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.39813330 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.37575845 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36617451 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36370999 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35852802 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.35131165 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34642690 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33938905 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33488095 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33276674 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32987752 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.32552529 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31375688 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.30952873 |
| 124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30760068 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.30445171 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28421823 |
| 127 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28193323 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27706118 |
| 129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27689255 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27604034 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27337449 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.26978849 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26401779 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25744133 |
| 135 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25540327 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25493464 |

